Literature DB >> 25698347

Empowering consumers as contributors for health product safety: lessons from the Philippines.

Kenneth Hartigan-Go1.   

Abstract

Empowering consumers to contribute to adverse drug reaction reporting seems a sensible innovation, particularly when traditional reports emanating from healthcare professionals are neither increasing nor improving. This work, inspired by an EU-FP7-funded project, describes an attempt by the Philippines to introduce a consumer reporting system through education and an online platform for reporting, and the lessons that were captured in the process. While participating consumers did not contribute to the adverse drug reporting process in the traditional sense as originally expected, the reports received by the drug regulatory agency revealed consumers' concerns regarding health product legitimacy, quality and market claims, as well as the lack of available and accessible information. These reports led regulators to take action. Initial insights on consumer behavior are proposed for regulators and industry to consider in greater depth and how this may impact on consumers providing valued information that will promote other aspects of product safety.

Mesh:

Substances:

Year:  2015        PMID: 25698347     DOI: 10.1007/s40264-015-0274-z

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  6 in total

Review 1.  Experiences with adverse drug reaction reporting by patients: an 11-country survey.

Authors:  Florence van Hunsel; Linda Härmark; Shanthi Pal; Sten Olsson; Kees van Grootheest
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  What motivates patients to report an adverse drug reaction?

Authors:  Florence P A M van Hunsel; Elaine A A M ten Berge; Sander D Borgsteede; Kees van Grootheest
Journal:  Ann Pharmacother       Date:  2010-04-13       Impact factor: 3.154

3.  Drug safety: reporting systems for the general public.

Authors:  June Munro Raine
Journal:  BMJ       Date:  2012-08-07

4.  Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins.

Authors:  Florence van Hunsel; Eugène van Puijenbroek; Lolkje de Jong-van den Berg; Kees van Grootheest
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-01       Impact factor: 2.890

5.  Challenges of drug risk communications in the Philippines.

Authors:  Kenneth Hartigan-Go
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

6.  Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

Authors:  Florence van Hunsel; Christine van der Welle; Anneke Passier; Eugène van Puijenbroek; Kees van Grootheest
Journal:  Eur J Clin Pharmacol       Date:  2010-07-24       Impact factor: 2.953

  6 in total
  1 in total

1.  The monitoring medicines project: a multinational pharmacovigilance and public health project.

Authors:  Shanthi N Pal; Sten Olsson; Elliot G Brown
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.